December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
ArriVent and Alphamab Partner in $615.5 million collaboration for Novel ADC Cancer Treatments – GeneOnline
Jun 8, 2024, 06:47

ArriVent and Alphamab Partner in $615.5 million collaboration for Novel ADC Cancer Treatments – GeneOnline

GeneOnline shared a post on LinkedIn:

ArriVent BioPharma and Alphamab Oncology announce a $615.5 million collaboration to develop and commercialize novel antibody-drug conjugates (ADCs) for cancer treatment. This partnership leverages cutting-edge ADC technology and global commercialization expertise.”

Further Reading.
Source: GeneOnline/LinkedIn